PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study
PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study Patient enrollment nears completion in investigational study expanding research of sacroiliac joint dysfunction treatment using a novel therapeutic device. News provided by Share this article Share this article TAMPA, Fla., March 15, 2021 /PRNewswire/ -- In the wave of innovative medical technology, PainTEQ, in partnership with Evolve Restorative Center in Santa Rosa, California and Celeri Health in Wilmington, Delaware, quickly nears enrollment completion of their single-arm multicenter prospective study exploring SI joint fu...